Coherus Oncology Inc (CHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Sales | 1,395 | 161 | 844 | 162,835 | 14,068 |
| Gross Profit | 1,395 | 161 | 844 | 162,835 | 14,068 |
| Operating Expenses | 58,033 | 72,578 | 74,304 | 78,218 | 76,804 |
| Operating Income | -56,638 | -72,417 | -73,460 | 84,617 | -62,736 |
| Interest Expense | 2,384 | 2,376 | 2,369 | 2,420 | 2,354 |
| Other Income | 3,620 | -29 | -115 | 1,647 | -5,060 |
| Pre-tax Income | -55,402 | -74,822 | -75,944 | 83,844 | -70,150 |
| Net Income Continuous | -55,402 | -74,822 | -75,944 | 83,844 | -70,150 |
| Minority Interests | -66 | -44 | -23 | -95 | -183 |
| Net Income | $-55,336 | $-74,778 | $-75,921 | $83,939 | $-69,967 |
| EPS Basic Total Ops | -1.08 | -1.54 | -1.58 | 1.93 | -1.72 |
| EPS Basic Continuous Ops | -1.08 | -1.54 | -1.58 | 1.93 | -1.72 |
| EPS Diluted Total Ops | -1.08 | -1.54 | -1.32 | 1.67 | -1.72 |
| EPS Diluted Continuous Ops | -1.08 | -1.54 | -1.27 | 1.63 | -1.72 |
| EBITDA(a) | $-55,782 | $-71,571 | $-72,663 | $85,370 | $-62,007 |